Herpes zoster, also called as shingles is an acute viral infection caused by the varicella-zoster virus, a similar one that causes chickenpox as well. Chickenpox is caused by the initial infection of the VZV virus; after chickenpox is cured, the virus remains inactive in the nerve cells and gets reactive travels to the nerve end, producing blisters. It can cause extreme rashes on the skin along with fever, headache, fatigue, and muscle weakness. The infection can affect anybody with a weak immune system and is primarily prevalent in older adults above the age of 50 years. The disease can be cured by oral medicines, topical and vaccines.
MARKET SCOPE
The "Global Herpes Zoster Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the herpes zoster drug market with detailed market segmentation by drug, vaccine, route of administration, distribution channel, end user, and geography. The report provides key statistics on the market status of the leading herpes zoster drug market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug, the global herpes zoster drug market is segmented into anti-viral agents, anti-inflammatory agents, analgesics, anticonvulsants agents, corticosteroids, tricyclic antidepressants, antihistamines and others.
- Based on vaccine, the market is segmented into zostavax, shingrix and others.
- Based on route of administration, the market is segmented into oral, topical, intravenous and others.
- On the basis of distribution channel, the market is bifurcated into online pharmacy, retailers and others.
- On the basis of end-users, the market is bifurcated into hospitals, homecare, specialty clinics and others.
MARKET DYNAMICS
Drivers:
- The rising prevalence of herpes zoster, rise in the occurrences of cancer and HIV patients, and increasing elderly population drive the herpes zoster drug market growth.
- Increasing vaccines and rising healthcare expenditure fuel the market growth.
- Technological developments and improving healthcare infrastructure propel market growth.
Restraints:
- High cost of the antibodies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The herpes zoster drug market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the herpes zoster drug market in these regions.
IMPACT OF COVID-19 ON HERPES ZOSTER DRUG MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The increasing prevalence of coronavirus pandemic and rapid rollout of COVID vaccines has led to a decline in sales of shingles vaccine that has impacted the herpes zoster drug market. Due to the prioritization of the public health systems to focus on pandemic vaccination deployment resulted in significant disruption in drug prescriptions. However, with strong underlying demand, the market is expected to witness growth in the future owing to the removal of restrictive measures and new policies by manufacturers.
MARKET PLAYERS
The report covers key developments in the herpes zoster drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from herpes zoster drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for herpes zoster drug in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the herpes zoster drug market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Pfizer Inc
- Abbott
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Astellas Pharma Inc.
- GeneOne Life Science
- Camber Pharmaceuticals